Molecular characterization of germline mutations in neurofibromatosis 2 in two families

被引:0
|
作者
Chen, HJ
Teng, HC
Li, SSL
机构
[1] Chang Gung Mem Hosp, Div Neurosurg, Kaohsiung, Taiwan
[2] Natl Sun Yat Sen Univ, Inst Life Sci, Kaohsiung 80424, Taiwan
关键词
neurofibromatosis; 2; schwannoma; tumor suppressor gene; phenotype;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neurofibromatosis 2 (NF2) is an autosomal dominant disorder that predisposes patients to central nervous system tumors. It is caused by mutations in the NF2 tumor suppressor gene, which is located on chromosome 22q12. We studied 2 multigenerational NF2 families (three members of family 1 and the proband of the family) by gene mutation analysis and clinical assessment. One member of family 1 had a 169 C-->T point mutation at codon 57 of exon 2 and bad a severe phenotype. His father had a silent 1113 C-->T point mutation at codon 371 of exon 11 and had a normal phenotype. The proband of family 2 had a deletion at nucleotide 720 G (codon 240) of exon 8. This led to a frameshift and termination at codon 250, and a severe NF2 phenotype. Our results indicate that clinical abnormalities can be present in carriers. Nonsense and frameshift mutations in the NF2 tumor suppressor gene are associated with phenotypes. The clinical abnormalities can develop at a young age.
引用
收藏
页码:869 / 872
页数:4
相关论文
共 50 条
  • [41] Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations
    Vital, A
    Bringuier, PP
    Huang, HT
    San Galli, F
    Rivel, J
    Ansoborlo, S
    Cazauran, JM
    Taillandier, L
    Kleihues, P
    Ohgaki, H
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (11): : 1061 - 1069
  • [42] Two novel and one known pathogenic germline mutations in MMRs in Chinese families with Lynch syndrome
    Li, Juyi
    Zhu, Lin
    Li, Yuanyuan
    Huang, Hui
    Huang, Kaiyu
    Deng, Aiping
    GENES & DISEASES, 2022, 9 (02) : 292 - 295
  • [43] Two novel mutations of the NF1 gene in Chinese Han families with type I neurofibromatosis
    Cai, YJ
    Fan, ZP
    Liu, QJ
    Du, J
    Shen, Y
    Wang, SL
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2005, 39 (02) : 125 - 127
  • [44] Clinical and Molecular Characterization of Fumarate Hydratase (FH) germline carriers in Omani families.
    Alsaegh, Abeer
    Abdulrahim, Reem
    Van Wyk, Chantel
    Crous, Ilse
    Al Kiyumi, Sara
    Al Balushi, Amira
    Al Malki, Suad
    Al Muhairi, Bushra
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1268 - 1268
  • [45] Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations
    Bishop, JAN
    Wachsmuth, RC
    Harland, M
    Bataille, V
    Pinney, E
    Mack, P
    Baglietto, L
    Cuzick, J
    Bishop, DT
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (01) : 28 - 33
  • [46] Screening for germline CHEK2 mutations in Spanish families with hereditary cancer suspicion
    del Valle, J.
    Vargas-Parra, G.
    Rofes, P.
    Gausachs, M.
    Stradella, A.
    Montes, E.
    Darder, E.
    Feliubadalo, L.
    Brunet, J.
    Lazaro, C.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1551 - 1552
  • [47] Molecular cloning of the human UMP synthase gene and characterization of point mutations in two hereditary orotic aciduria families
    Suchi, M
    Mizuno, H
    Kawai, Y
    Tsuboi, T
    Sumi, S
    Okajima, K
    Hodgson, ME
    Ogawa, H
    Wada, Y
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (03) : 525 - 539
  • [48] CHARACTERIZATION OF GERMLINE MUTATIONS OF THE GENE ENCODING BRUTONS TYROSINE KINASE IN FAMILIES WITH X-LINKED AGAMMAGLOBULINEMIA
    HAGEMANN, TL
    ROSEN, FS
    KWAN, SP
    HUMAN MUTATION, 1995, 5 (04) : 296 - 302
  • [49] Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer
    Yang, Xiaohong R.
    Jessop, Lea
    Myers, Timothy
    Amundadottir, Laufey
    Pfeiffer, Ruth M.
    Wheeler, William
    Pike, Kristen M.
    Yuenger, Jeff
    Burdett, Laurie
    Yeager, Meredith
    Chanock, Stephen J.
    Tucker, Margaret A.
    Goldstein, Alisa M.
    FAMILIAL CANCER, 2011, 10 (03) : 545 - 548
  • [50] Two families with new MAPT gene mutations: Clinical and biochemical characterization
    Nakayama, S.
    Shimonaka, S.
    Elahi, M.
    Oji, Y.
    Matsumoto, S. E.
    Li, Y.
    Yoshino, H.
    Nishioka, K.
    Hatano, T.
    Motoi, Y.
    Hattori, N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 765 - 765